# Fractyl Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fractyl-health

- Industry: Medical Devices & Equipment
- Headquarters: Lexington, US
- Website: www.fractyl.com
- Total disclosed funding: $286M
- Latest round: Series F (Jun 16, 2021)
- Investors on record: 17

## About

Based in Massachusetts, US, founded in 2010 by co-founders Harith Rajagopalan and Jay Caplan, Fractyl Health, Inc. developer of a health device that provides treatments for patients with metabolic diseases. In June 2021, Fractyl Health raised USD 100 million of Series F funding. In February 2024, Fractyl Health, Inc. raised USD 110 million in an IPO, selling 7.33 million shares at USD 15 per share, within the expected USD 14-16 range, on the Nasdaq Global Select Market under the ticker symbol "GUTS". Fractyl Health, Inc. has granted the underwriters a 30-day option to purchase up to an additional 1.09 million shares of common stock as part of the listing.

Fractyl Health developed Revita™ DMR, a surgical device used in procedural therapy that rejuvenates the lining of the duodenum. The company also provides treatments for patients with conditions resulting from insulin resistance, including type 2 diabetes, nonalcoholic steatohepatitis, and polycystic ovarian syndrome with the help of cell and gene therapy.

Fractyl Health plans to expand and accelerate its clinical development in reducing insulin dependence for patients with type 2 diabetes on a global scale.

## Funding rounds

- Series F, Jun 16, 2021, $100M — Maverick Capital, M28 Capital, Population Health Partners
- Series E, Aug 6, 2020, $55M — Domain Associates, General Catalyst Partners, Bessemer Venture Partners, Emergent Medical Ventures, GV, Mithril, CDIB Ventures, Z Venture Capital, Taiwania Capital, Catalio Capital Management
- Series D, Dec 14, 2017, $5.6M — Domain Associates, General Catalyst Partners, True Ventures, Bessemer Venture Partners, Deerfield Capital Management, Emergent Medical Ventures, GV, Mithril
- Series D, Jun 19, 2017, $38M — Domain Associates, General Catalyst Partners, True Ventures, Bessemer Venture Partners, Emergent Medical Ventures, GV, Mithril, Deerfield Management, IDO Investments
- Series C, Feb 19, 2016, $10M — Domain Associates, General Catalyst Partners, Bessemer Venture Partners, Mithril, Deerfield Management
- Series C, Oct 23, 2015, $37M — Domain Associates, General Catalyst Partners, Bessemer Venture Partners, Mithril, Deerfield Management
- Series C, Aug 19, 2014, $20M — Domain Associates, General Catalyst Partners, Bessemer Venture Partners, Mithril
- Series B, Mar 8, 2013, $14M — Domain Associates, General Catalyst Partners, Bessemer Venture Partners
- Series A, Jun 23, 2011, $5.5M — Bessemer Venture Partners

## Investors

- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series A, Series B, Series C, Series D, Series E
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series C, Series D, Series E
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series B, Series C, Series D, Series E
- Mithril (https://capitalatlas.ai/funds/mithril) — Series C, Series D, Series E
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series C, Series D
- True Ventures (https://capitalatlas.ai/funds/true-ventures) — Series D
- Emergent Medical Ventures (https://capitalatlas.ai/funds/emergent-medical-ventures) — Series D, Series E
- GV (https://capitalatlas.ai/funds/gv) — Series D, Series E
- IDO Investments (https://capitalatlas.ai/funds/ido-investments) — Series D
- Deerfield Capital Management (https://capitalatlas.ai/funds/deerfield-capital-management) — Series D
- CDIB Ventures — Series E
- Z Venture Capital (https://capitalatlas.ai/funds/z-venture-capital) — Series E
- Taiwania Capital (https://capitalatlas.ai/funds/taiwania-capital) — Series E
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series E
- Maverick Capital (https://capitalatlas.ai/funds/maverick-capital) — Series F
- M28 Capital — Series F
- Population Health Partners (https://capitalatlas.ai/funds/population-health-partners) — Series F